Longitude Capital Partners, Llc - Net Worth and Insider Trading
Longitude Capital Partners, Llc Net Worth
The estimated net worth of Longitude Capital Partners, Llc is at least $93 Million dollars as of 2024-09-20. Longitude Capital Partners, Llc is the 10% Owner of Collegium Pharmaceutical Inc and owns about 2,321,842 shares of Collegium Pharmaceutical Inc (COLL) stock worth over $91 Million. Longitude Capital Partners, Llc is also the 10% Owner of Esperion Therapeutics Inc and owns about 1,434,396 shares of Esperion Therapeutics Inc (ESPR) stock worth over $2 Million. Details can be seen in Longitude Capital Partners, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Longitude Capital Partners, Llc has not made any transactions after 2017-12-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Longitude Capital Partners, Llc
Longitude Capital Partners, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Longitude Capital Partners, Llc owns 3 companies in total, including Collegium Pharmaceutical Inc (COLL) , Corcept Therapeutics Inc (CORT) , and Esperion Therapeutics Inc (ESPR) .
Click here to see the complete history of Longitude Capital Partners, Llc’s form 4 insider trades.
Insider Ownership Summary of Longitude Capital Partners, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| COLL | Collegium Pharmaceutical Inc | 2017-12-08 | 10 percent owner |
| CORT | Corcept Therapeutics Inc | 2008-03-25 | director & 10 percent owner |
| ESPR | Esperion Therapeutics Inc | 2014-11-18 | 10 percent owner |
Longitude Capital Partners, Llc Latest Holdings Summary
Longitude Capital Partners, Llc currently owns a total of 2 stocks. Among these stocks, Longitude Capital Partners, Llc owns 2,321,842 shares of Collegium Pharmaceutical Inc (COLL) as of December 8, 2017, with a value of $91 Million and a weighting of 97.41%. Longitude Capital Partners, Llc also owns 1,434,396 shares of Esperion Therapeutics Inc (ESPR) as of November 18, 2014, with a value of $2 Million and a weighting of 2.59%.
Latest Holdings of Longitude Capital Partners, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| COLL | Collegium Pharmaceutical Inc | 2017-12-08 | 2,321,842 | 39.06 | 90,691,149 |
| ESPR | Esperion Therapeutics Inc | 2014-11-18 | 1,434,396 | 1.68 | 2,409,785 |
Holding Weightings of Longitude Capital Partners, Llc
Longitude Capital Partners, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Longitude Capital Partners, Llc has made a total of 0 transactions in Collegium Pharmaceutical Inc (COLL) over the past 5 years. The most-recent trade in Collegium Pharmaceutical Inc is the sale of 1,000,000 shares on December 8, 2017, which brought Longitude Capital Partners, Llc around $17 Million.
According to the SEC Form 4 filings, Longitude Capital Partners, Llc has made a total of 0 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years. The most-recent trade in Esperion Therapeutics Inc is the sale of 487,130 shares on November 18, 2014, which brought Longitude Capital Partners, Llc around $16 Million.
Insider Trading History of Longitude Capital Partners, Llc
- 1
Longitude Capital Partners, Llc Trading Performance
GuruFocus tracks the stock performance after each of Longitude Capital Partners, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Longitude Capital Partners, Llc is 34.75%. GuruFocus also compares Longitude Capital Partners, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Longitude Capital Partners, Llc within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Longitude Capital Partners, Llc's insider trading performs compared to the benchmark.
Performance of Longitude Capital Partners, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 37.36 | | | | | |
| Relative Return to S&P 500(%) | 34.63 | | | | | |
Longitude Capital Partners, Llc Ownership Network
Longitude Capital Partners, Llc Owned Company Details
What does Collegium Pharmaceutical Inc do?
Who are the key executives at Collegium Pharmaceutical Inc?
Longitude Capital Partners, Llc is the 10 percent owner of Collegium Pharmaceutical Inc. Other key executives at Collegium Pharmaceutical Inc include EVP and Chief Medical Officer Thomas B Smith , EVP and General Counsel Shirley R. Kuhlmann , and EVP & Chief Financial Officer Tupper Colleen .
Collegium Pharmaceutical Inc (COLL) Insider Trades Summary
Over the past 18 months, Longitude Capital Partners, Llc made no insider transaction in Collegium Pharmaceutical Inc (COLL). Other recent insider transactions involving Collegium Pharmaceutical Inc (COLL) include a net sale of 198,212 shares made by Joseph Ciaffoni , a net sale of 88,809 shares made by Shirley R. Kuhlmann , and a net sale of 141,576 shares made by Scott Dreyer .
In summary, during the past 3 months, insiders sold 29,818 shares of Collegium Pharmaceutical Inc (COLL) in total and bought 0 shares, with a net sale of 29,818 shares. During the past 18 months, 486,885 shares of Collegium Pharmaceutical Inc (COLL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 486,885 shares.
Collegium Pharmaceutical Inc (COLL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Collegium Pharmaceutical Inc Insider Transactions
Longitude Capital Partners, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Longitude Capital Partners, Llc. You might contact Longitude Capital Partners, Llc via mailing address: 800 El Camino Real, Suite 220, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
